Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT00226096 Completed - Clinical trials for Intracranial Hemorrhages

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Start date: November 2005
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.

NCT ID: NCT00224757 Completed - Stroke Clinical Trials

Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study

TIARA
Start date: September 2005
Phase: N/A
Study type: Interventional

In this multi centre pilot study we will perform TEE in patients with AF who are eligible for VKA treatment. TTE will be used as pre-screening: if TTE shows left atrial abnormalities or aortic plaque, patients will be excluded from randomisation. TEE will be performed in all other patients to detect or exclude complex aorta plaques or signs of left atrial stasis. Three hundred patients who do not have these features on TTE will be randomly assigned to treatment with aspirin or VKA. Follow-up will be 1 year.

NCT ID: NCT00224237 Completed - Stroke Clinical Trials

Exploring Folk Health Practices in Latinos With Chronic Medical Conditions

Start date: December 2005
Phase: N/A
Study type: Observational

This study will explore how culture influences the use of folk healing practices and medical services in Latinos with chronic medical conditions.

NCT ID: NCT00223847 Completed - Stroke Clinical Trials

An Investigation of Constraint Induced Language Therapy for Aphasia

Start date: August 2002
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of intensive, constraint induced language therapy (CILT) for individuals with chronic aphasia compared with traditional aphasia therapy. The specific objectives of the proposed research are to determine the effects of therapy type (CILT vs. traditional) and dose density (intensive or distributed) on speech therapy outcome. In addition, we will investigate the functional and qualitative impact of these interventions on functional communication.

NCT ID: NCT00222339 Completed - Stroke Clinical Trials

Task-Related Training of Arm Use After Stroke

Start date: February 2002
Phase: N/A
Study type: Interventional

Stroke is the leading cause of long-term physical disability in Australia. Currently around 25% of hemiplegic stroke patients discharged from rehabilitation have significantly impaired use of the affected hand with consequent dependence in dressing, grooming and feeding themselves. The poor outcome can be attributed in part to a lack of focus by therapists on the negative signs of stroke (weakness and lack of dexterity) as well as too little time (around 10 minutes per day) being devoted to retraining of the arm. Presently there is a very limited evidence base to guide the content of clinical practice. Results from both animal and human studies suggest that specific post-lesion training can result in substantial improvement in function. The hypothesis is that task-specific training of the affected upper limb to subjects in the early period following stroke will result in significantly better functional outcome than standard intervention.

NCT ID: NCT00221390 Completed - Clinical trials for Cerebrovascular Accident

Trial of Ropinirole in Motor Recovery After Stroke

Start date: October 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.

NCT ID: NCT00221104 Completed - Ischemic Stroke Clinical Trials

Japan Statin Treatment Against Recurrent Stroke (J-STARS)

Start date: March 1, 2004
Phase: Phase 3
Study type: Interventional

Although hyperlipidemia is not always the risk factor of stroke, inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-CoA) reductase can decrease the incidence of stroke in the patient with ischemic heart disease. The neuroprotective mechanism beyond cholesterol lowering should be expected to attenuate inflammation and atherosclerosis. The present study hypothesizes if pravastatin prevents recurrent stroke in the ischemic stroke patients with safety.

NCT ID: NCT00221078 Completed - Stroke Clinical Trials

Benefits of Applying Neuroprosthesis for Improving Reaching and Grasping Functions in Stroke Patients

Start date: April 2003
Phase: Phase 3
Study type: Interventional

Functional electrical stimulation (FES) is a process that uses low intensity electrical pulses generated by an electric stimulator to create muscle contractions. By contracting muscles in a specific sequence, one can generate various body functions such as grasping, walking, and standing. Final goal of the study is to evaluate if FES training when applied early during rehabilitation will help stroke patients to use their hands more effectively after discharge from a rehabilitation facility, compared to those patients who have not received FES training.

NCT ID: NCT00221065 Completed - Clinical trials for Cerebrovascular Accident

Effect of Continuous Positive Airway Pressure (CPAP) on Cognitive and Functional Performance in Stroke Patients With Obstructive Sleep Apnea

Start date: June 2005
Phase: Phase 3
Study type: Interventional

" Obstructive sleep apnea"(OSA) is a sleep breathing disorder. When a person with OSA tries to sleep the back of the throat closes and blocks the flow of air into lungs.When this happens, a person's sleep is disrupted, causing minor awakenings(which the individual may not recognize). This occurs many times throughout the night, causing poor sleep quality,excessive daytime sleepiness, poor concentration, and sometimes depression.It is possible that poor outcomes observed in stroke patients with OSA result from these neurocognitive phenomena, presumably by reducing effective participation in rehabilitation activities.OSA is treated with nasal continuous positive airway pressure(CPAP).CPAP therapy keeps the back of the throat open so that airflow is never blocked.The study is designed to investigate whether treatment of OSA with CPAP improves the results of rehabilitation.

NCT ID: NCT00216411 Completed - Clinical trials for Cerebrovascular Accident

Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm

Start date: November 2004
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to assess the effect on Quality of Life of two cycles of Dysport treatment on post-stroke spasticity of the upper limb. The effect of treatment on spasticity and function will also be measured.